Welcome from NHRC
Welcome from NHRC
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Adjuvant radiotherapy has no benefit following radical prostatectomy
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
Cost-benefit analysis of new cancer medicines: The difficult choices of governments
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
OncoAlert Round Up for September 22-28, 2023
OncoAlert Round Up for September 15-21, 2023
OncoAlert Round Up for September 8-14, 2023